Results 11 to 20 of about 375,109 (185)
BMC Pharmacology and Toxicology, 2018 Background Drug induced immune hemolytic anemia (DIIHA) is a rare complication and often underdiagnosed. DIIHA is frequently associated with a bad outcome, including organ failure and even death. For the last decades, ceftriaxone has been one of the most
Hans Benno Leicht +5 more
doaj +2 more sources
Annals of Hematology, 2022 COVID-19 is a global pandemic triggered by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 entry point involves the interaction with angiotensin-converting enzyme 2 (ACE2) receptor, CD147, and erythrocyte Band3 protein ...
H. Al-kuraishy +4 more
semanticscholar +1 more source
Rambam Maimonides Medical Journal, 2021 Gaucher disease (GD) is an autosomal recessive disease characterized by the buildup of glucocerebrosides in macrophages, resulting in the formation of “Gaucher cells.” These cells predominantly infiltrate the liver, spleen, and bone marrow leading to ...
Eliyakim Hershkop +4 more
doaj +1 more source
How I treat warm autoimmune hemolytic anemia.
Blood, 2021 Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by IgG autoantibodies, with or without complement activation.
W. Barcellini, B. Fattizzo
semanticscholar +1 more source
Traumatic Hemolytic Anemia after Valve Surgery: a Case Report [PDF]
Folia Medica, 2020 Hemolytic anemia is an uncommon complication after mitral valve repair. We present a case of a 55-year-old man who presented with post-operative hemolytic anemia after mitral valve repair with prosthetic ring.
Feridoun Sabzi +2 more
doaj +3 more sources
How I treat microangiopathic hemolytic anemia in patients with cancer
Blood, 2021 Diagnosis and treatment of acquired hemolytic anemia can be challenging. In this How I Treat series, edited by Mario Cazzola, clinical experts discuss their approaches to the treatment of patients with 4 different classes of acquired hemolytic anemia.
M. Thomas, M. Scully
semanticscholar +1 more source
Autoimmune Hemolytic Anemia in the Pediatric Setting
Journal of Clinical Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease in children, presenting with variable severity. Most commonly, warm-reactive IgG antibodies bind erythrocytes at 37 °C and induce opsonization and phagocytosis mainly by the splenic macrophages ...
A. Voulgaridou, T. Kalfa
semanticscholar +1 more source
PLoS ONE, 2022 BackgroundImmune hemolytic anemia commonly affects human immune deficiency infected individuals. Among anemic HIV patients in Africa, the burden of IHA due to autoantibody was ranged from 2.34 to 3.06 due to drug was 43.4%.
Samuel Sahile Kebede +5 more
doaj +2 more sources
Hemolytic Anemia Complicating COVID-19 Infection
Journal of Hematology, 2021 Coronavirus disease 2019 (COVID-19) has been associated with a spectrum of reported hematological complications ranging from immune cytopenias to thromboembolic manifestations of coagulopathy.
Abeer N. Abouyabis, Grace Thompson Bell
semanticscholar +1 more source
The Autoimmune Hemolytic Anemia following Septic Shock with Escherichia Coli; a Case Report
Archives of Academic Emergency Medicine, 2023 Sepsis is a severe, life-threatening illness caused when the immune system responds inappropriately to infections, causing organ deterioration and negatively affecting the systems inside the body, one of which is the coagulation system. Most hematologic
Duong Le Xuan +5 more
doaj +1 more source